Research & Development
∙ Federal and private research grants and contracts of approximately $250 million in fiscal year 2018.
∙ In 2006 the Nobel Prize in Physiology or Medicine was awarded to UMMS professor Craig C. Mello, PhD, for their discoveries related to RNA interference (RNAi), a cellular process that offers astounding potential for understanding and, ultimately treating, human disease.
∙ UMMS research programs are central to the
Massachusetts Life Sciences Initiative, with major funding from the $1 billion since 2008.
∙We utilize state of the art technologies to either edit mutated genes that produce disease-causing proteins or introduce a healthy copy of a gene if the mutation results in a non-functional protein.
∙The University of Massachusetts conducts clinical trial on site and some of these trials are conducted by the investigators at the Gene Therapy center.
∙The RTI is dedicated to leveraging the strong RNA biology and clinical research communities at UMMS to develop novel therapies for which RNA is the therapeutic target or modality.
∙The RNA Therapeutics Institute faculty are recognized as scientific trailblazers, and include a Nobel Laureate, a Gairdner Prize recipient, the 2018 RNA Society early and mid-career award recipients, and two Howard Hughes Medical Institute Investigators.